Loading organizations...
Blissvine Ventures is a venture capital firm scaling technology and life science companies. It employs a dual investment strategy, funding nascent startups under three years old alongside more established late-stage ventures. Investments primarily target Seed and Series A rounds in sectors like biotechnology, healthcare, financial software, and personal products.
The firm is associated with Jay Kim, a key figure in venture capital. Its foundation stems from understanding the distinct capital and strategic support companies need at various development stages. This approach seeks to identify and foster potential within its chosen industries.
Blissvine Ventures partners with innovative companies, accelerating their market entry and expansion. Its vision guides portfolio companies through growth milestones, fostering their evolution into market leaders. The firm cultivates a robust network of thriving enterprises, ensuring long-term impact in its supported sectors.
Blissvine Ventures has 2 tracked investments across 2 companies. The latest tracked deal is $1.0M Other Equity in Adler in February 2024.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Feb 1, 2024 | Adler | $1.0M Other Equity | Woohyun NAM | Ensl Partners, Evergreen Investment Partners |
| Nov 20, 2023 | Huject | $1.4M Pre-Series A | — | Ecopro Partners, Hanyang University Technology Holdings, IPS Ventures, Woohyun NAM |